Group 1: Product Advantages - The starch capsules are made from 100% natural starch and purified water, ensuring safety and non-toxicity [3] - The capsules do not undergo cross-linking reactions, making them chemically inert and safe for use with common pharmaceuticals [3] - No chemical additives such as preservatives or colorants are used in the production process [3] - The stability of the starch capsules is high due to their simple molecular structure, which is less prone to bacterial growth and spoilage [3] - The company has a subsidiary in Cambodia that produces 180,000 tons of cassava starch annually, ensuring a stable supply of raw materials for capsule production [3] Group 2: Market Potential - The global capsule market has a total production of over 1.4 trillion units in 2014, with gelatin capsules accounting for 95% of this market [4] - There are approximately 1.6 billion Muslims, 1 billion Hindus, and a growing number of vegetarians globally, creating a wider audience for starch capsules [4] - The company’s starch capsules have received certifications from the EU Vegetarian Society, Clean Certification, and Kosher Certification, enhancing market competitiveness [4] - The future application of capsules is expected to expand, as they are easier to swallow and can shorten the time to market for pharmaceuticals [4] Group 3: Sales Strategy - The company employs a multi-channel sales strategy, combining online and offline methods, including e-commerce, B2B sales, and overseas markets [3] - The current selling price of starch capsules through e-commerce platforms is 0.32 yuan per capsule, indicating a high added value [4] Group 4: Strategic Development - The company is working on a non-public offering project, currently in the review and feedback stage by the regulatory authority [5] - The establishment of an internet-based trading service platform for pharmaceutical excipients aims to enhance supply chain management and customer satisfaction [5] - The company has successfully overcome technical barriers in the industrialization of starch plant capsules, establishing a complete industrial chain from raw materials to end sales [5][6]
尔康制药(300267) - 2015年6月19日投资者关系活动记录表